NAFLD

Loss of hepatic Mboat7 leads to liver fibrosis
Veera Raghavan Thangapandi, Oskar Knittelfelder, Mario Brosch, Eleonora Patsenker, Olga Vvedenskaya, Stephan Buch, Sebastian Hinz, Alexander Hendricks, Marina Nati, Alexander Herrmann, Devavrat Ravindra Rekhade, Thomas Berg, Madlen Matz-Soja, Klaus Huse, Edda Klipp, Josch K Pauling, Judith AH Wodke, Jacobo Miranda Ackerman, Malte von Bonin, Elmar Aigner, Christian Datz, Witigo von Schönfels, Sophie Nehring, Sebastian Zeissig, Christoph Röcken, Andreas Dahl, Triantafyllos Chavakis, Felix Stickel, Andrej Shevchenko, Clemens Schafmayer, Jochen Hampe, Pallavi Subramanian

Gut May 2021, 70 (5) 940-950; DOI: 10.1136/gutjnl-2020-320853
Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis
Oliver Krenkel, Jana Hundertmark, Ali T Abdallah, Marlene Kohlhepp, Tobias Puengel, Tilmann Roth, Diogo Philippini Pontual Branco, Jana C Mossanen, Tom Luedde, Christian Trautwein, Ivan G Costa, Frank Tacke

Gut Mar 2020, 69 (3) 551-563; DOI: 10.1136/gutjnl-2019-318382
PTH-109 Is the soaring prevalence of nafld flying under the radar of hospital staff?
Nurun Tania, Bronwen Williams, Lynsey Corless

Gut Jun 2018, 67 (Suppl 1) A133; DOI: 10.1136/gutjnl-2018-BSGAbstracts.265
Take me to the liver: adipose tissue macrophages coordinate hepatic neutrophil recruitment
Gerard Pernes, Graeme I Lancaster, Andrew J Murphy

Gut Jul 2018, 67 (7) 1204-1206; DOI: 10.1136/gutjnl-2017-315393
PWE-094 The severity of steatosis does not influence liver stiffness measurements in patients with non-alcoholic fatty liver disease
R Forlano, BH Mullish, N Angkathunyakul, E Goldin, M Yee, G Serviddio, N Giannakeas, AT Tzallas, MG Tsipouras, F Rui, S Khan, S Taylor-Robinson, RD Goldin, M Thursz, P Manousou

Gut Jul 2017, 66 (Suppl 2) A174-A175; DOI: 10.1136/gutjnl-2017-314472.340
PWE-075 Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of south asian descent
S De Silva, W Li, P Kemos, J Brindley, J Mecci, S Samsuddin, J Chin-Aleong, R Feakins, G Foster, W-K Syn, W Alazawi

Gut Jul 2017, 66 (Suppl 2) A164; DOI: 10.1136/gutjnl-2017-314472.321
PWE-076 What is the meaning of low lysosomal acid lipase (lal) levels in the hepatology and metabolic clinic?
M Pericleous, C Kelly, T Wang, C Livingstone, A Ala

Gut Jul 2017, 66 (Suppl 2) A164-A165; DOI: 10.1136/gutjnl-2017-314472.322
PWE-090 The liver as the homeostatic alarm: abnormal liver function tests precede the onset of diabetes mellitusby more than two years
MB Protty, HN Haboubi, F Yousuf, A Yeoman, S Jenkins, M Czajkowski

Gut Jul 2017, 66 (Suppl 2) A172; DOI: 10.1136/gutjnl-2017-314472.336
PTU-059 Burden of liver disease in the west midlands: increased premature mortality
N Bhala, S Haroon, S Burwood, C Pennell, H Carter, A Daley, E Day, A El Sharkaway, J Ferguson, D Freshwater, V Gordon, A Holt, A Mittal, J Mukarati, I Perry, A Phillips, N Quann, M Tahir, R Thomson, E Unitt, C Bray, N Dennis, G Wrench, and on behalf of the West Midlands Liver Health Collaborative Network

Gut Jul 2017, 66 (Suppl 2) A80; DOI: 10.1136/gutjnl-2017-314472.154
PTU-092 An integrated primary and secondary care algorithm for non-alcoholic fatty liver disease significantly increases community screening for hepatitis b and c infection
K Bicknell, K Fancey, K Gamble, J Dowman, A Fowell, R Aspinall

Gut Jul 2017, 66 (Suppl 2) A97; DOI: 10.1136/gutjnl-2017-314472.188

Main menu

NAFLD

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

NAFLD

Pages